Related Experiment Video
Updated: Aug 21, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Tumor-derived Parathyroid Hormone-Related Protein Is Associated with Suppression of Cytochrome P450 Expression:
Issei Fujita1, Tsubasa Kaji2, Isamu Noguchi2
1Department of Clinical Pharmacy and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.
Abstract:
Cancer cachexia is frequently associated with altered pharmacokinetics and increased chemotherapy toxicity due to the downregulation of cytochrome P450 (CYP) enzymes. However, the molecular mechanisms driving this broad metabolic suppression remain poorly understood. This study investigated whether tumor-derived parathyroid hormone-related protein (PTHrP) is associated with, and may contribute to, suppression of multiple CYP families. In a rat cachexia model, protein expression of CYP3A, CYP1A, CYP2C, CYP2D, and CYP2E1 was significantly downregulated in both the liver and small intestine. Consistent with these changes, pharmacokinetic analyses using a CYP substrate cocktail demonstrated markedly increased AUC and reduced clearance for probe drugs. In vitro experiments showed that PTHrP treatment reduced these CYP isoforms in primary rat hepatocytes. In human data sets, analysis of The Cancer Genome Atlas (TCGA) hepatocellular carcinoma (HCC) data set revealed a significant negative correlation between PTHrP and CYP gene expression, together with enrichment of NF-κB-related transcriptional programs. Furthermore, multimodal analysis using single-cell RNA sequencing and spatial transcriptomics demonstrated that PTHrP-high tumor regions exhibit suppressed xenobiotic metabolism. Additionally, in breast cancer liver metastases, high tumor PTHrP expression correlated with reduced CYP expression in surrounding nontumor hepatocytes, consistent with a possible paracrine relationship. Collectively, these results support an association between tumor-derived PTHrP and suppression of drug-metabolizing programs. They further suggest that PTHrP may be one contributing factor, but not definitive proof of a principal suppressor, and should therefore be considered a candidate biomarker requiring further mechanistic and clinical validation.
Insights
Tumor-derived parathyroid hormone-related protein (PTHrP) is linked to suppressed drug metabolism in cancer cachexia by downregulating cytochrome P450 (CYP) enzymes. This suggests PTHrP may be a biomarker for altered drug pharmacokinetics.
Area of Science:
- Pharmacology
- Oncology
- Biochemistry
Background:
- Cancer cachexia often involves altered drug metabolism and increased chemotherapy toxicity.
- Downregulation of cytochrome P450 (CYP) enzymes contributes to these metabolic changes.
- The precise molecular mechanisms behind this broad metabolic suppression are not fully understood.
Purpose of the Study:
- To investigate the association between tumor-derived parathyroid hormone-related protein (PTHrP) and the suppression of multiple CYP enzyme families.
- To determine if PTHrP contributes to the downregulation of drug-metabolizing enzymes in cancer cachexia.
Main Methods:
- Utilized a rat cachexia model to assess CYP expression and pharmacokinetics.
- Conducted in vitro experiments with primary rat hepatocytes and PTHrP treatment.
- Analyzed human The Cancer Genome Atlas (TCGA) hepatocellular carcinoma (HCC) data.
- Employed single-cell RNA sequencing and spatial transcriptomics for detailed analysis.
Main Results:
- Significant downregulation of CYP3A, CYP1A, CYP2C, CYP2D, and CYP2E1 in liver and small intestine of cachectic rats.
- Increased drug AUC and reduced clearance observed in pharmacokinetic analyses.
- PTHrP treatment reduced CYP isoform expression in primary rat hepatocytes.
- Negative correlation between PTHrP and CYP gene expression in human HCC data, linked to NF-κB pathways.
- PTHrP-high tumor regions showed suppressed xenobiotic metabolism.
- High tumor PTHrP correlated with reduced CYP expression in adjacent nontumor hepatocytes in liver metastases.
Conclusions:
- Tumor-derived PTHrP is associated with the suppression of drug-metabolizing CYP enzymes in cancer cachexia.
- PTHrP is a potential contributing factor to the metabolic suppression observed in cancer patients.
- PTHrP warrants further investigation as a candidate biomarker for altered drug metabolism and toxicity, requiring mechanistic and clinical validation.
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...